Appili Therapeutics

Appili announces dosing of first patient in phase 3 Covid-19 trial
Pharmaceutical Business Review
Thu, 12/3/20 - 10:50 am
Appili Therapeutics
COVID-19
Avigan
clinical trials
FDA clears Appili Therapeutics to expand its trial of favipiravir for prrevention of Covid-19
Pharmaceutical Business Review
Tue, 08/11/20 - 12:34 pm
Appili Therapeutics
FDA
antivirals
favipiravir
clinical trials
COVID-19